BioCentury
ARTICLE | Financial News

Aug. 19 Financial Quick Takes: Juvenescence raises $100M Series B; plus 10X, IGM propose IPOs

August 20, 2019 12:14 AM UTC

Juvenescence closes $100M series B
Juvenescence Ltd. (Douglas, Isle of Man) said it has closed its $100 million series B round and reiterated plans to seek an IPO. Investors included the company's founders plus Grok Ventures and IPGL. The company, which is focused on developing therapeutics to for age-related diseases and to extend human longevity, raised $46 million for the round's first tranche in January (see "Juvenescence’s Market Watch").

10x Genomics, IGM file for NASDAQ listings
10x Genomics Inc. (Pleasanton, Calif.) and IGM Biosciences Inc. (Mountain View, Calif.) each proposed Monday to raise up to $100 million through an IPO...